Shire is a speciality biopharmaceutical company with the single-minded vision of enabling people with life-altering conditions to lead better lives. The focus at Shire is on working to develop treatments that make a tangible difference in patients’ lives.
Working alongside patients, caregivers and physicians for many years, Shire has gained extensive insight in ADHD. This knowledge has led to the understanding that ADHD is a diverse disorder and that individuals affected by ADHD have widely different needs.
Shire will continue to develop treatments with the aim of allowing healthcare professionals to meet the unique needs of individuals with ADHD.
Shire supports independent organisations and actively participates in major medical conferences and education programmes to raise awareness of ADHD, support healthcare professionals in managing the disorder and improve the lives of people affected by the condition.